Pernix Therapeutics to buy Great Southern Laboratories
The assets under certain liabilities include Great Southern’s buildings and land located in Houston, Texas, US. The acquisition will enable Pernix to improve the company’s gross margins on
US-based gene therapy biotech Seawolf Therapeutics and Sanofi have signed a multi-target research partnership and exclusive licensing deal worth up to $1.2bn to develop treatments for bleeding disorders and other undisclosed indications.
Under the collaboration, Cellworks will leverage its proprietary predictive platform to model drug MDR-TB and rationally identify synergistic combinations with highest possible efficacy and lowest possible toxic burden